Clinical Trials Logo

Clinical Trial Summary

Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with standard of care). The headset is combined with a mini-global positioning system (GPS)-like system to help navigate to treat tumor(s). This evaluation is to show that the headset has potential to provide guidance and navigation information that can improve the treatment of tumor(s) with heat.


Clinical Trial Description

This protocol will clinically evaluate new 3D holographic guidance and navigation for percutaneous ablation of solid tumors to ultimately overcome limitations of displaying images on 2D flat-panel monitors ("flat screens"). 3D Holographic percutaneous ablation (3D HPA) provides real-time, 360° visualization for guidance and navigation of tracked interventional instruments augmented to the operative site. In this preliminary protocol, 3D HPA will be evaluated as an adjunct to flat-screen display of conventional images used for guidance (ultrasound, fluoroscopy, CT), in accordance with standard of care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03500757
Study type Observational
Source Case Comprehensive Cancer Center
Contact
Status Enrolling by invitation
Phase
Start date April 29, 2018
Completion date August 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02813005 - High Frequency Jet Ventilation for Percutaneous Interventional Radiology Phase 3